prostadine reviews
Prostate cancer, also known as adenocarcinoma, is a malignant cancer that starts in the prostate. It is the most common form of cancer in men in the United States and occurs most often in men who have been diagnosed with benign prostatic hyperplasia (BPH), but it can also occur in men with no prostate problems. Prostate cancer affects the prostate gland, which is the sizable, walnut-shaped gland that lies beneath a man’s bladder and surrounds the urethra (the tube that passes urine from the bladder out of the body).
There is a close relationship between benign prostatic hyperplasia (BPH) and prostate cancer (PCa). Both conditions often occur in men aged over 50 years old and can lead to serious complications. However, while the exact causes of BPH are not yet known, there are several risk factors that have been established. Men with BPH are at an increased risk of developing PCa and vice versa.
Furthermore, men with BPH are usually more likely to develop
aggressive forms of PCa. This has serious implications for disease
management as it means that doctors must take the patient’s prostate
health into consideration when making treatment decisions. In this
article, we will discuss the relationship between BPH and PCa, the
clinical significance of this association, and some suggestions on how
to manage and prevent these conditions.